Beat Weber
25Patents
4h-index
45Co-inventors
63Inventor score
Filing activity: Jul 27, 2001 → Nov 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6673838B2 | Succinate salt of O-desmethyl-venlafaxine | Chemistry; Metallurgy | 26 | Expired |
| US6689912B2 | Methods for preparing O-desmethylvenlafaxine | Chemistry; Metallurgy | 12 | Expired |
| US6441201B1 | Method for the preparation of 5-cyanophthalide | Chemistry; Metallurgy | 9 | Expired |
| US10597363B2 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C | Chemistry; Metallurgy | 8 | Active |
| US8921557B2 | Preparation of low impurity opiates in a continuous flow reactor | Chemistry; Metallurgy | 4 | Active |
| US10981871B2 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C | Chemistry; Metallurgy | 4 | Active |
| US10981870B2 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form | Chemistry; Metallurgy | 4 | Active |
| US7795425B2 | Production of bepromoline | Chemistry; Metallurgy | 2 | Active |
| US11225500B2 | Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene, L-proline and water | Chemistry; Metallurgy | 1 | Active |
| US11629161B2 | Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ß-d-glucopyranos-1-yl)-benzene, L-proline and water | Chemistry; Metallurgy | 1 | Active |
| US8049007B2 | Preparation of amorolfine | Chemistry; Metallurgy | 1 | Active |
| US7435854B2 | Methods for preparing O-desmethylvenlafaxine | Chemistry; Metallurgy | 0 | Active |
| US10391091B2 | Method of manufacturing buprenorphine and analogues thereof from oripavine | Chemistry; Metallurgy | 0 | Active |
| US11407730B2 | Preparation of racemic nicotine by reaction of ethyl nicotinate with N-vinylpyrrolidone in the presence of an alcoholate base and subsequent process steps | Human Necessities | 0 | Active |
| US10822304B2 | Process for the production of N-Boc-2-amino-3,3-dimethylbutyric acid | Chemistry; Metallurgy | 0 | Active |
| US11279685B2 | Enantiomeric separation of racemic nicotine by addition of an O,O″-disubstituted tartaric acid enantiomer | Human Necessities | 0 | Active |
| US10035807B2 | Method of manufacturing stereoisomers of buprenorphine and analogues thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11840515B2 | Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c | Chemistry; Metallurgy | 0 | Active |
| US11091458B2 | Preparation of racemic nicotine by reaction of ethyl nicotinate with N-vinylpyrrolidone in the presence of an alcoholate base and subsequent process steps | General | 0 | Revoked |
| US8242268B2 | Production of bepromoline | Chemistry; Metallurgy | 0 | Active |
| US9546177B2 | Synthesis of noroxymorphone from morphine | Emerging Cross-Sectional Technologies | 0 | Active |
| US8106231B2 | Process for the preparation of (2R,3S)-3-phenylisoserine methyl ester acetate salt | Chemistry; Metallurgy | 0 | Active |
| US10329268B2 | Processes for preparing medicaments for the treatment of cardiovascular diseases and intermediates for use therein | Chemistry; Metallurgy | 0 | Active |
| US10927122B2 | Synthesis of noroxymorphone | Human Necessities | 0 | Active |
| US10738058B2 | Method of manufacturing 4-chloro-7H-pyrrolo[2,3-D]pyrimidine | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.